Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: A correlation study

Journal of Pediatric Gastroenterology and Nutrition

Volumn 48, Issue 3, 2009, Pages 306-310

  Weintraub, Amir ^a   Blau, Hannah ^b   Mussaffi, Huda ^b   Picard, Elie ^c   Bentur, Lea ^d   Kerem, Eitan ^a   Stankiewicz, Halina ^c   Wilschanski, Michael ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Cystic fibrosis; Exocrine pancreatic insufficiency; Immunoreactive trypsinogen; Pancreatic elastase 1; Steatorrhea

Indexed keywords

ELASTASE; ELASTASE I; IMMUNOREACTIVE TRYPSINOGEN; TRYPSINOGEN; UNCLASSIFIED DRUG; PANCREATIC ELASTASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYSTIC FIBROSIS; FECES ANALYSIS; FEMALE; HUMAN; INFANT; LIPID ABSORPTION; MALE; PANCREAS FUNCTION; PANCREAS FUNCTION TEST; PANCREAS INSUFFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEATORRHEA; BLOOD; ENZYMOLOGY; FAT INTAKE; FECES; METABOLISM; PANCREAS; PANCREAS EXOCRINE INSUFFICIENCY; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; CYSTIC FIBROSIS; DIETARY FATS; EXOCRINE PANCREATIC INSUFFICIENCY; FECES; FEMALE; HUMANS; INFANT; MALE; PANCREAS; PANCREATIC ELASTASE; SENSITIVITY AND SPECIFICITY; TRYPSINOGEN;

EID: 67650376409     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318180af4f     Document Type: Article

References (18)

1. Kerem E, Conway S, Elborn S, et al. Consensus committee. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005;4:7-26.
2. Löser C, Möllgaard A, Fölsch UR. Faecal elastase 1: a novel, highly sensitive and specific tubeless pancreatic function test. Gut 1996;39:580-6.
3. Stein J, Jung M, Sziegoleit A, et al. Immunoreactive elastase 1: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem 1996;42:222-6.
4. Bowling FG, Watson AR, Rylatt DB, et al. Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis. Lancet 1987;11:826-7.
5. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1988;132:589-95.
6. Van de Kamer JH, Bokkel Huinink H, Weyers HA. Rapid method for the determination of fat in feces. J Biol Chem 1949;177:347-55.
7. Walkowiak J, Herzig KH, Strzykala K, et al. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 2002;110:e7.
8. Beharry S, Ellis L, Corey M, et al. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr 2002;141:84-90.
9. Geokas MC, Largman C, Brodrick JW, et al. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay. Am J Physiol 1979;236:E77-83.
10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 8476:307-10.
11. Cohen JR, Schall JI, Ittenbach RF, et al. Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2005;40:438-44.
12. Cleghorn G, Benjamin L, Corey M, et al. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis. Pediatrics 1986;77:301-6.
13. Walkowiak J, Lisowska A, Przyslawski J. Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis. Acta Paediatr 2004;93:1042-5.
14. Walkowiak J, Cichy WK, Herzig KH. Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis. Scand J Gastroenterol 1999;34:202-7.
15. Siegmund E, Lohr JM, Schuff-Werner P. The diagnostic validity of non-invasive pancreatic function tests - a meta-analysis. Z Gastroenterol 2004;42:1117-28.
16. Meyts I, Wuyts W, Proesmans M. Variability of fecal pancreatic elastase measurements in cystic fibrosis patients. J Cyst Fibros 2002;1:265-8.
17. Schibli S, Corey M, Gaskin KJ, et al. Towards the ideal quantitative pancreatic function test: analysis of test variables that influence validity. Clin Gastroenterol Hepatol 2006;4:90-7.
18. Walkowiak J, Nousia-Arvanitakis S, Agguridaki C, et al. Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test. J Pediatr Gastroenterol Nutr 2003;36:474-8.